News
ESSA PHARMA ANNOUNCES FILING OF PRELIMINARY SHELF PROSPECTUS AND REGISTRATION STATEMENT
ESSA PHARMA INC. REPORTS FINANCIAL RESULTS FOR THE FOURTH QUARTER AND YEAR ENDED SEPTEMBER 30, 2015
ESSA Announces Enrollment of First Patient in Phase 1/2 Trial
ESSA Pharma Inc. Receives Health Canada Approval to Commence Clinical Development for EPI-506
ESSA Pharma Inc. Receives FDA Approval to Commence Clinical Development
ESSA PHARMA INC. REPORTS THIRD QUARTER 2015 FINANCIAL RESULTS
ESSA Pharma Inc. to Commence Trading on the Toronto Stock Exchange
ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market
ESSA Pharma Inc. Announces Appointment of New Director
ESSA PHARMA INC. REPORTS SECOND QUARTER 2015 FINANCIAL RESULTS